The global protein expression market size was estimated at USD 4.68 billion in 2024 and is anticipated to reach around USD 12.27 billion by 2034, expanding at a CAGR of 10.12% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
Protein Expression Market
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Protein Expression Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Protein Expression Market, by Expression System
8.1.1. Prokaryotic Expression Systems
8.1.1.1. Market Revenue and Forecast
8.1.2. Eukaryotic Expression Systems
8.1.2.1. Market Revenue and Forecast
9.1. Protein Expression Market, by Product Type
9.1.1. Reagents
9.1.1.1. Market Revenue and Forecast
9.1.2. Instruments
9.1.2.1. Market Revenue and Forecast
9.1.3. Services
9.1.3.1. Market Revenue and Forecast
10.1. Protein Expression Market, by Application
10.1.1. Therapeutic Development
10.1.1.1. Market Revenue and Forecast
10.1.2. Research Applications
10.1.2.1. Market Revenue and Forecast
10.1.3. Industrial Applications
10.1.3.1. Market Revenue and Forecast
11.1. Protein Expression Market, by End-User
11.1.1. Pharmaceutical and Biotechnology Companies
11.1.1.1. Market Revenue and Forecast
11.1.2. Academic and Research Institutes
11.1.2.1. Market Revenue and Forecast
11.1.3. Contract Research Organizations (CROs)
11.1.3.1. Market Revenue and Forecast
11.1.4. CMOs and CDMOs
11.1.4.1. Market Revenue and Forecast
11.1.5. Diagnostic Laboratories
11.1.5.1. Market Revenue and Forecast
12.1. Protein Expression Market, by Expression Method/Technology
12.1.1. Stable Expression
12.1.1.1. Market Revenue and Forecast
12.1.2. Transient Expression
12.1.2.1. Market Revenue and Forecast
12.1.3. Cell-free Protein Synthesis
12.1.3.1. Market Revenue and Forecast
12.1.4. Inducible Expression Systems
12.1.4.1. Market Revenue and Forecast
12.1.5. Constitutive Expression Systems
12.1.5.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Expression System
13.1.2. Market Revenue and Forecast, by Product Type
13.1.3. Market Revenue and Forecast, by Application
13.1.4. Market Revenue and Forecast, by End-User
13.1.5. Market Revenue and Forecast, by Expression Method/Technology
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Expression System
13.1.6.2. Market Revenue and Forecast, by Product Type
13.1.6.3. Market Revenue and Forecast, by Application
13.1.6.4. Market Revenue and Forecast, by End-User
13.1.6.5. Market Revenue and Forecast, by Expression Method/Technology
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Expression System
13.1.7.2. Market Revenue and Forecast, by Product Type
13.1.7.3. Market Revenue and Forecast, by Application
13.1.7.4. Market Revenue and Forecast, by End-User
13.1.7.5. Market Revenue and Forecast, by Expression Method/Technology
13.2. Europe
13.2.1. Market Revenue and Forecast, by Expression System
13.2.2. Market Revenue and Forecast, by Product Type
13.2.3. Market Revenue and Forecast, by Application
13.2.4. Market Revenue and Forecast, by End-User
13.2.5. Market Revenue and Forecast, by Expression Method/Technology
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Expression System
13.2.6.2. Market Revenue and Forecast, by Product Type
13.2.6.3. Market Revenue and Forecast, by Application
13.2.7. Market Revenue and Forecast, by End-User
13.2.8. Market Revenue and Forecast, by Expression Method/Technology
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Expression System
13.2.9.2. Market Revenue and Forecast, by Product Type
13.2.9.3. Market Revenue and Forecast, by Application
13.2.10. Market Revenue and Forecast, by End-User
13.2.11. Market Revenue and Forecast, by Expression Method/Technology
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Expression System
13.2.12.2. Market Revenue and Forecast, by Product Type
13.2.12.3. Market Revenue and Forecast, by Application
13.2.12.4. Market Revenue and Forecast, by End-User
13.2.13. Market Revenue and Forecast, by Expression Method/Technology
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Expression System
13.2.14.2. Market Revenue and Forecast, by Product Type
13.2.14.3. Market Revenue and Forecast, by Application
13.2.14.4. Market Revenue and Forecast, by End-User
13.2.15. Market Revenue and Forecast, by Expression Method/Technology
13.3. APAC
13.3.1. Market Revenue and Forecast, by Expression System
13.3.2. Market Revenue and Forecast, by Product Type
13.3.3. Market Revenue and Forecast, by Application
13.3.4. Market Revenue and Forecast, by End-User
13.3.5. Market Revenue and Forecast, by Expression Method/Technology
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Expression System
13.3.6.2. Market Revenue and Forecast, by Product Type
13.3.6.3. Market Revenue and Forecast, by Application
13.3.6.4. Market Revenue and Forecast, by End-User
13.3.7. Market Revenue and Forecast, by Expression Method/Technology
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Expression System
13.3.8.2. Market Revenue and Forecast, by Product Type
13.3.8.3. Market Revenue and Forecast, by Application
13.3.8.4. Market Revenue and Forecast, by End-User
13.3.9. Market Revenue and Forecast, by Expression Method/Technology
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Expression System
13.3.10.2. Market Revenue and Forecast, by Product Type
13.3.10.3. Market Revenue and Forecast, by Application
13.3.10.4. Market Revenue and Forecast, by End-User
13.3.10.5. Market Revenue and Forecast, by Expression Method/Technology
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Expression System
13.3.11.2. Market Revenue and Forecast, by Product Type
13.3.11.3. Market Revenue and Forecast, by Application
13.3.11.4. Market Revenue and Forecast, by End-User
13.3.11.5. Market Revenue and Forecast, by Expression Method/Technology
13.4. MEA
13.4.1. Market Revenue and Forecast, by Expression System
13.4.2. Market Revenue and Forecast, by Product Type
13.4.3. Market Revenue and Forecast, by Application
13.4.4. Market Revenue and Forecast, by End-User
13.4.5. Market Revenue and Forecast, by Expression Method/Technology
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Expression System
13.4.6.2. Market Revenue and Forecast, by Product Type
13.4.6.3. Market Revenue and Forecast, by Application
13.4.6.4. Market Revenue and Forecast, by End-User
13.4.7. Market Revenue and Forecast, by Expression Method/Technology
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Expression System
13.4.8.2. Market Revenue and Forecast, by Product Type
13.4.8.3. Market Revenue and Forecast, by Application
13.4.8.4. Market Revenue and Forecast, by End-User
13.4.9. Market Revenue and Forecast, by Expression Method/Technology
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Expression System
13.4.10.2. Market Revenue and Forecast, by Product Type
13.4.10.3. Market Revenue and Forecast, by Application
13.4.10.4. Market Revenue and Forecast, by End-User
13.4.10.5. Market Revenue and Forecast, by Expression Method/Technology
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Expression System
13.4.11.2. Market Revenue and Forecast, by Product Type
13.4.11.3. Market Revenue and Forecast, by Application
13.4.11.4. Market Revenue and Forecast, by End-User
13.4.11.5. Market Revenue and Forecast, by Expression Method/Technology
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Expression System
13.5.2. Market Revenue and Forecast, by Product Type
13.5.3. Market Revenue and Forecast, by Application
13.5.4. Market Revenue and Forecast, by End-User
13.5.5. Market Revenue and Forecast, by Expression Method/Technology
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Expression System
13.5.6.2. Market Revenue and Forecast, by Product Type
13.5.6.3. Market Revenue and Forecast, by Application
13.5.6.4. Market Revenue and Forecast, by End-User
13.5.7. Market Revenue and Forecast, by Expression Method/Technology
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Expression System
13.5.8.2. Market Revenue and Forecast, by Product Type
13.5.8.3. Market Revenue and Forecast, by Application
13.5.8.4. Market Revenue and Forecast, by End-User
13.5.8.5. Market Revenue and Forecast, by Expression Method/Technology
14.1. Agilent Technologies Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Bio-Rad Technologies
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Thermo Fisher Scientific Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Merck KGA
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Takara Bio Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. New England Biolabs Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Oxford Expression Technologies Ltd
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Promega Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Qiagen NV
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Sigma-Aldrich Corporation.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description